Published in J Clin Epidemiol on February 01, 1999
NSAID use and dementia risk in the Cardiovascular Health Study: role of APOE and NSAID type. Neurology (2007) 1.88
Racial and ethnic disparities in cardiovascular medication use among older adults in the United States. Pharmacoepidemiol Drug Saf (2010) 1.19
Physical activity and change in estimated GFR among persons with CKD. J Am Soc Nephrol (2013) 1.08
An exploratory study on medications in Qatar homes. Drug Healthc Patient Saf (2011) 1.05
A computer-based approach for assessing dietary supplement use in conjunction with dietary recalls. J Food Compost Anal (2008) 1.05
Association between emphysema-like lung on cardiac computed tomography and mortality in persons without airflow obstruction: a cohort study. Ann Intern Med (2014) 1.03
Non-adherence to aspirin or oral anticoagulants in secondary prevention after ischaemic stroke. J Neurol (2005) 0.96
Assessment of physical activity in chronic kidney disease. J Ren Nutr (2012) 0.92
Calcium Intake From Diet and Supplements and the Risk of Coronary Artery Calcification and its Progression Among Older Adults: 10-Year Follow-up of the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Heart Assoc (2016) 0.84
Demographic, medical, and behavioral characteristics associated with over the counter non-steroidal anti-inflammatory drug use in a population-based cohort: results from the Multi-Ethnic Study of Atherosclerosis. Pharmacoepidemiol Drug Saf (2010) 0.84
Patterns and predictors of recovery from exhaustion in older adults: the cardiovascular health study. J Am Geriatr Soc (2011) 0.84
Drug-gene interactions and the search for missing heritability: a cross-sectional pharmacogenomics study of the QT interval. Pharmacogenomics J (2013) 0.84
Intercellular adhesion molecule 1 and progression of percent emphysema: the MESA Lung Study. Respir Med (2014) 0.82
Drug-Gene Interactions of Antihypertensive Medications and Risk of Incident Cardiovascular Disease: A Pharmacogenomics Study from the CHARGE Consortium. PLoS One (2015) 0.81
H2 receptor antagonists and right ventricular morphology: the MESA right ventricle study. Ann Am Thorac Soc (2014) 0.79
Self-rated health and adverse events in CKD. Clin J Am Soc Nephrol (2014) 0.78
Prediction and classification of cardiovascular disease risk in older adults with diabetes. Diabetologia (2012) 0.78
Associations between aspirin and other non-steroidal anti-inflammatory drugs and aortic valve or coronary artery calcification: the Multi-Ethnic Study of Atherosclerosis and the Heinz Nixdorf Recall Study. Atherosclerosis (2013) 0.77
Cognitive Impairment and Medication Complexity in Community-Living Older Adults: The Health, Aging and Body Composition Study. J Pharm Technol (2012) 0.77
The relationship between self-reported and registry-based data on use of psychoactive medications in postmenopausal women. BMC Psychiatry (2013) 0.77
Time trends in the use of anti-hypertensive medications: results from the Multi-Ethnic Study of Atherosclerosis. Pharmacoepidemiol Drug Saf (2009) 0.75
Testosterone, Dihydrotestosterone, Sex Hormone Binding Globulin and Incident Diabetes among Older Men: the Cardiovascular Health Study. J Clin Endocrinol Metab (2016) 0.75
Histamine H2 Receptor Antagonists, Left Ventricular Morphology, and Heart Failure Risk: The MESA Study. J Am Coll Cardiol (2016) 0.75
Validity of self-report of lipid medication use: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis (2015) 0.75
Pulmonary vascular volume, impaired left ventricular filling and dyspnea: The MESA Lung Study. PLoS One (2017) 0.75
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med (1997) 18.85
Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. Ann Epidemiol (1995) 10.26
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation (1995) 9.13
Assessing the sensitivity of regression results to unmeasured confounders in observational studies. Biometrics (1998) 8.48
Laboratory methods and quality assurance in the Cardiovascular Health Study. Clin Chem (1995) 7.73
Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation (2000) 7.37
The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA (1995) 7.31
Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med (1999) 6.92
Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA (1997) 5.91
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol (2000) 5.59
Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials. Lancet (2000) 5.42
The messenger under attack -- intimidation of researchers by special-interest groups. N Engl J Med (1997) 5.14
Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc (1999) 4.84
Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem (1997) 4.77
Community-level comparisons between the grocery store environment and individual dietary practices. Prev Med (1991) 4.45
Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group. Stroke (1991) 4.21
Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am J Epidemiol (2000) 4.16
Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol (1994) 4.08
Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet (1999) 4.07
Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. Am J Epidemiol (1996) 3.82
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Diabetes in older adults: comparison of 1997 American Diabetes Association classification of diabetes mellitus with 1985 WHO classification. Lancet (1998) 3.61
Are drugs within a class interchangeable? Lancet (1999) 3.58
JNC VI: timing is everything. Lancet (1997) 3.48
The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord (2001) 3.39
Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int (2000) 3.29
Time to act on drug safety. JAMA (1998) 3.22
Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med (1994) 3.04
The association of antihypertensive agents with MRI white matter findings and with Modified Mini-Mental State Examination in older adults. J Am Geriatr Soc (1997) 2.98
Serum potassium level and dietary potassium intake as risk factors for stroke. Neurology (2002) 2.98
Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation (1998) 2.83
British guidelines on managing hypertension. Provide evidence, progress, and an occasional missed opportunity. BMJ (1999) 2.83
Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol (1997) 2.76
Subclinical disease as an independent risk factor for cardiovascular disease. Circulation (1995) 2.71
Association between physical activity and markers of inflammation in a healthy elderly population. Am J Epidemiol (2001) 2.68
The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes (2001) 2.47
Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study. J Thromb Haemost (2007) 2.40
Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study. Atherosclerosis (2001) 2.40
Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst (1999) 2.40
Differences in sociodemographic, health status, and lifestyle characteristics among American Indians by telephone coverage. Prev Med (1994) 2.37
Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem (1999) 2.35
Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Circulation (1999) 2.31
The association between cholesterol and death from injury. Ann Intern Med (1994) 2.26
Family history as a risk factor for primary cardiac arrest. Circulation (1998) 2.25
Antihypertensive drug therapies and the risk of ischemic stroke. Arch Intern Med (2001) 2.24
Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes. Diabetes Care (2000) 2.22
Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum (1999) 2.21
Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease. JAMA (1999) 2.21
Inflammation in cardiovascular disease: cart, horse, or both? Circulation (1998) 2.18
Treatment of hypertensive patients with diabetes. Lancet (1998) 2.16
Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood (1997) 2.15
Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol (1999) 2.15
The unnecessary controversy. Eur Heart J (1996) 2.05
Trends in pharmacologic management of hypertension in the United States. Arch Intern Med (1995) 2.04
Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol (1997) 1.90
Major electrocardiographic abnormalities in persons aged 65 years and older (the Cardiovascular Health Study). Cardiovascular Health Study Collaborative Research Group. Am J Cardiol (1992) 1.89
NSAID use and dementia risk in the Cardiovascular Health Study: role of APOE and NSAID type. Neurology (2007) 1.88
The medical cost of undiagnosed sleep apnea. Sleep (1999) 1.86
HMG CoA reductase inhibitors and the risk of venous thrombosis among postmenopausal women. J Thromb Haemost (2004) 1.85
Lipoprotein lipids in older people. Results from the Cardiovascular Health Study. The CHS Collaborative Research Group. Circulation (1992) 1.79
Hypertension and its treatment in postmenopausal women: baseline data from the Women's Health Initiative. Hypertension (2000) 1.77
Cardiovascular disease mortality in familial forms of hypertriglyceridemia: A 20-year prospective study. Circulation (2000) 1.76
Vascular events, mortality, and preventive therapy following ischemic stroke in the elderly. Neurology (2005) 1.76
Epidemiology of low cholesterol levels in older adults. The Cardiovascular Health Study. Circulation (1993) 1.75
Analytical and biologic variability in measures of hemostasis, fibrinolysis, and inflammation: assessment and implications for epidemiology. Am J Epidemiol (1999) 1.73
Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups. Neurology (2004) 1.72
Validity and reliability of auditory screening tests in demented and non-demented older adults. J Gen Intern Med (1989) 1.64
Risk of stroke in young women and two prothrombotic mutations: factor V Leiden and prothrombin gene variant (G20210A) Stroke (1998) 1.63
Prevalence of cardiovascular diseases among older adults. The Cardiovascular Health Study. Am J Epidemiol (1993) 1.63
Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study. Kidney Int (2000) 1.62
Activating communities for health promotion: a process evaluation method. Am J Public Health (1993) 1.60
The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women. Arch Intern Med (1994) 1.60
Do communities differ in health behaviors? J Clin Epidemiol (1993) 1.60
ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). J Thromb Haemost (2007) 1.59
Data analysis and sample size issues in evaluations of community-based health promotion and disease prevention programs: a mixed-model analysis of variance approach. J Clin Epidemiol (1991) 1.59
T helper-cell phenotype regulates atherosclerosis in mice under conditions of mild hypercholesterolemia. Circulation (2001) 1.57
Cholesterol reduction and the risk for stroke in men. A meta-analysis of randomized, controlled trials. Ann Intern Med (1993) 1.53
Intracerebral hemorrhage related to cerebral amyloid angiopathy and t-PA treatment. Ann Neurol (1991) 1.46
Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB Trial) Am J Cardiol (1996) 1.46
Level of blood pressure and risk of myocardial infarction among treated hypertensive patients. Arch Intern Med (1992) 1.45
No advantage of A beta 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies. Neurology (2008) 1.45
Risk factors for hip fracture among patients with end-stage renal disease. Kidney Int (2000) 1.44
Common genetic variation near the connexin-43 gene is associated with resting heart rate in African Americans: a genome-wide association study of 13,372 participants. Heart Rhythm (2012) 1.43
Randomized intervention to increase children's selection of low-fat foods in school lunches. J Pediatr (1994) 1.42